Clinical trial
Spectrometry for TIA Rapid Assessment (SpecTRA) Project: Study 2-Validation of Clinical Features and Protein Biomarkers
NCT03070067 is registered in ClinicalTrials.gov with Andrew Penn as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Spectrometry for TIA Rapid Assessment (SpecTRA) Project: Study 2-Validation of Clinical Features and Protein Biomarkers
- Lead sponsor
- Andrew Penn
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2015
- Completion date
- March 31, 2017
- Enrollment
- 1,150 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
tia